SE8902588L - Intravenoes farmaceutisk komposition samt foerfarande foer framstaellning av densamma - Google Patents

Intravenoes farmaceutisk komposition samt foerfarande foer framstaellning av densamma

Info

Publication number
SE8902588L
SE8902588L SE8902588A SE8902588A SE8902588L SE 8902588 L SE8902588 L SE 8902588L SE 8902588 A SE8902588 A SE 8902588A SE 8902588 A SE8902588 A SE 8902588A SE 8902588 L SE8902588 L SE 8902588L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
mass
intravenoe
procedures
preparation
Prior art date
Application number
SE8902588A
Other languages
English (en)
Other versions
SE8902588D0 (sv
SE509174C2 (sv
Inventor
E Orban
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of SE8902588D0 publication Critical patent/SE8902588D0/sv
Publication of SE8902588L publication Critical patent/SE8902588L/sv
Publication of SE509174C2 publication Critical patent/SE509174C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8902588A 1988-07-21 1989-07-21 Intravenös, farmaceutisk komposition innehållande cyklosporin samt förfarande för framställning av densamma SE509174C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU883796A HU201567B (en) 1988-07-21 1988-07-21 Process for production of intravenous medical compositions containing cyclosphorin

Publications (3)

Publication Number Publication Date
SE8902588D0 SE8902588D0 (sv) 1989-07-21
SE8902588L true SE8902588L (sv) 1990-01-22
SE509174C2 SE509174C2 (sv) 1998-12-14

Family

ID=10965544

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902588A SE509174C2 (sv) 1988-07-21 1989-07-21 Intravenös, farmaceutisk komposition innehållande cyklosporin samt förfarande för framställning av densamma

Country Status (26)

Country Link
US (1) US5047396A (sv)
JP (1) JPH07116051B2 (sv)
KR (1) KR0137674B1 (sv)
AR (1) AR243382A1 (sv)
AT (1) AT402258B (sv)
AU (1) AU614862B2 (sv)
BE (1) BE1004323A4 (sv)
CA (1) CA1332712C (sv)
CH (1) CH679120A5 (sv)
DD (1) DD283934A5 (sv)
DE (1) DE3924207A1 (sv)
DK (1) DK175540B1 (sv)
FI (1) FI92556C (sv)
FR (1) FR2635265B1 (sv)
GB (1) GB2221157B (sv)
GR (1) GR1002184B (sv)
HU (1) HU201567B (sv)
IL (1) IL91069A (sv)
IT (1) IT1231434B (sv)
LU (1) LU87560A1 (sv)
NL (1) NL194578C (sv)
NO (1) NO175287C (sv)
NZ (1) NZ230036A (sv)
PT (1) PT91246B (sv)
SE (1) SE509174C2 (sv)
ZA (1) ZA895588B (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
DE4412201A1 (de) * 1993-04-20 1994-11-10 Rentschler Arzneimittel Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
RU2158601C2 (ru) * 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
NZ313899A (en) * 1995-08-25 2000-03-27 Univ North Carolina Oral cyclosporin compositions comprising cyclosporin A, a solvent either ethanol or propylene glycol and one non-ionic polyoxyethylene surfactant selected from polyoxyethylene alcohols and mono-esters of ethoxylated sorbitans
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
DE19549852B4 (de) * 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
RU2211047C2 (ru) 1997-01-30 2003-08-27 Новартис Аг Желатиновые капсулы с твердым покрытием, включающие фармацевтические композиции, практически не содержащие масел
HU228855B1 (en) * 1997-03-12 2013-06-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
AT408186B (de) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag Wässerige zubereitung von beta-carotin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10015814A1 (de) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
FR2826517B1 (fr) * 2001-06-20 2004-03-12 Somfy Dispositif d'alimentation pour store motorise ou similaire
AR036852A1 (es) * 2001-10-19 2004-10-06 Isotechnika Inc Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
JP4815418B2 (ja) * 2007-10-19 2011-11-16 カヤバ工業株式会社 空圧緩衝器
MX2011002688A (es) * 2008-09-12 2011-04-12 Critical Pharmaceuticals Ltd Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel.
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
WO2012125569A2 (en) 2011-03-11 2012-09-20 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
AU2016315873B2 (en) 2015-09-04 2022-08-18 Primatope Therapeutics Inc. Humanized anti-CD40 antibodies and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU534955B2 (en) * 1980-01-23 1984-02-23 Sandoz Ag Cyclosporin a to treat lymphoproliferative disorders
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3339235A1 (de) * 1983-10-28 1985-05-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von polyurethanen
JPH02501389A (ja) * 1987-10-02 1990-05-17 フセソユズニ　カルディオロジチェスキ　ナウチニ　ツェントル　アカデミイ　メディツィンスキフ　ナウク　エスエスエスエル 多発性硬化症及び筋萎縮側索硬化症の治療用薬用製剤
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US4943560A (en) * 1988-04-06 1990-07-24 Regents Of The University Of Minnesota Solvent system for chronic vascular infusion of hydrophobic drugs
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
KR0137674B1 (ko) 1998-05-15
NO892995D0 (no) 1989-07-21
FI92556C (sv) 1994-12-12
AR243382A1 (es) 1993-08-31
GB2221157B (en) 1991-12-18
NL8901902A (nl) 1990-02-16
DD283934A5 (de) 1990-10-31
NL194578C (nl) 2002-08-05
CH679120A5 (sv) 1991-12-31
PT91246B (pt) 1995-05-04
NO175287B (no) 1994-06-20
SE8902588D0 (sv) 1989-07-21
LU87560A1 (fr) 1991-02-18
SE509174C2 (sv) 1998-12-14
AU614862B2 (en) 1991-09-12
ZA895588B (en) 1990-07-25
AU3884589A (en) 1990-02-01
AT402258B (de) 1997-03-25
BE1004323A4 (fr) 1992-11-03
CA1332712C (en) 1994-10-25
GR890100467A (el) 1990-06-27
FI893520A0 (sv) 1989-07-21
GB8916679D0 (en) 1989-09-06
ATA176789A (de) 1996-08-15
PT91246A (pt) 1990-02-08
DK175540B1 (da) 2004-11-29
FR2635265A1 (fr) 1990-02-16
NL194578B (nl) 2002-04-02
FI92556B (sv) 1994-08-31
DK362189D0 (da) 1989-07-21
IL91069A (en) 1993-07-08
IT8921259A0 (it) 1989-07-21
NO892995L (no) 1990-01-22
GR1002184B (en) 1996-03-12
DE3924207A1 (de) 1990-01-25
US5047396A (en) 1991-09-10
JPH03115227A (ja) 1991-05-16
GB2221157A (en) 1990-01-31
HUT50851A (en) 1990-03-28
JPH07116051B2 (ja) 1995-12-13
IT1231434B (it) 1991-12-04
FR2635265B1 (fr) 1995-03-17
NO175287C (no) 1994-09-28
NZ230036A (en) 1991-02-26
FI893520A (sv) 1990-01-22
HU201567B (en) 1990-11-28
KR900001364A (ko) 1990-02-27
DK362189A (da) 1990-01-22
DE3924207C2 (sv) 1992-07-09

Similar Documents

Publication Publication Date Title
SE8902588D0 (sv) Intravenoes farmaceutisk komposition samt foerfarande foer framstaellning av densamma
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
SE8104661L (sv) Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav
IE790704L (en) Cyclosporin composition
BG101117A (en) New medicamentous forms of cyclosporin for oral application of no complex composition and high bioactivity and method for their preparation
ES2042520T3 (es) Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.
AU2059088A (en) A device for the administration of implants
RU94033520A (ru) Впрыскиваемый лецитиновый гель
FI880163A (sv) Förfarande för framställning av en lösning som kan användas som läkemedel
HU885868D0 (en) Process for producing compounds antagonizing effect of hormon releasing luteinizing hormon and pharmaceutical preparatives containing said compounds as active substance
BE1003009A5 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
FI930746A0 (fi) Heterocykliska foereningar och deras framstaellning och anvaendning
FI923347A0 (fi) Blodfaktorer producerade med rekombinant-dna-teknik och foerfarande foer expression av naemnda blodfaktorer samt i naemnda foerfarande anvaenda rekombinanta kokoppvirus.
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
SE8703032L (sv) Perkutan administrering av lekemedel
DE69210879D1 (de) Gellanester
WO1995023586A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
ATE96662T1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
KR890008171A (ko) 펩타이드 구조물, 이를 함유하는 면역원 및 수정율 억제에 있어서 이의 용도
SE8006550L (sv) Farmakologisk komposition, samt sett for dess framstellning
ES2032757T3 (es) Inyecciones que contienen alcohol poliprenilico y el uso de estas.
DK430380A (da) Fremgangsmaade til fremstilling af piperidinderivater af 4,5-dialkyl-3-hydroxypyrrol-2-carboxylsyreestere
ES8401721A1 (es) Un procedimiento para la produccion de una composicion de fenortrazina inyectable.
IL82639A0 (en) Transdermal pharmaceutical composition

Legal Events

Date Code Title Description
NUG Patent has lapsed